1 unchanged sentence
Market Information
−Removed: Our common stock is publicly traded on the NASDAQ Global Select Market under the symbol “COLL” since May 7, 2015.
+Added: Our common stock has been publicly traded on the NASDAQ Global Select Market under the symbol “COLL” since May 7, 2015.
Prior to May 7, 2015, there was no public trading market for our common stock.
3 unchanged sentences
Stock Performance Graph
−Removed: The following graph shows a comparison from May 7, 2015, the date on which our common stock first began trading on the NASDAQ Global Select Market, of the total cumulative shareholder return on an assumed investment of $100.00 in cash in our common stock as compared to the same investment in the NASDAQ Composite Index and the NASDAQ Biotechnology Index, all through December 31, 2022.
+Added: The following graph sets forth the Company’s total cumulative shareholder return as compared to the NASDAQ Composite Index and the NASDAQ Biotechnology Index for the 5-year period beginning on December 31, 2018 through December 31, 2023.
+Added: Total cumulative shareholder return assumes an investment of $100.00 in cash in our common stock at the beginning of the 5-year period compared to the same investment in the NASDAQ Composite Index and the NASDAQ Biotechnology Index.
Such returns are based on historical results and are not intended to suggest future performance.
8 unchanged sentences
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
−Removed: The following table sets forth shares of Common Stock repurchased under our repurchase program authorized by our Board of Directors in August 2021 (the “Prior Repurchase Program”), as well as shares transferred to us from employees in satisfaction of minimum tax withholding obligations associated with the vesting of performance share units and restricted stock units during the three months ended December 31, 2022:
+Added: The following table sets forth shares of common stock repurchased under our repurchase program authorized by our Board of Directors in January 2023 (the “2023 Repurchase Program”), as well as shares transferred to us from employees in satisfaction of minimum tax withholding obligations associated with the vesting of performance share units and restricted stock units during the three months ended December 31, 2023:
Total number of shares purchased
2 unchanged sentences
Maximum approximate dollar value of Shares that may yet be purchased under the plans or programs
+Added: (in thousands)
October 1, 2023 through October 31, 2023
1 unchanged sentence
December 1, 2023 through December 31, 2023
−Removed: (1) The Prior Repurchase Program was announced on August 16, 2021.
−Removed: The Prior Repurchase Program provided for the repurchase of up to $100 million of outstanding shares of our common stock at any time or times through December 31, 2022.
−Removed: The Prior Repurchase Program expired December 31, 2022 with approximately $38.1 million available for repurchase at the time of expiration.
+Added: (1) The 2023 Repurchase Program was announced on January 4, 2023.
+Added: The 2023 Repurchase Program provided for the repurchase of up to $100.0 million of outstanding shares of our common stock at any time or times through December 31, 2023.
+Added: The 2023 Repurchase Program expired on December 31, 2023 with approximately $25.0 million available for repurchase at the time of expiration.
(2) The difference, if any, between the total number of shares purchased and the total number of shares purchased as part of a publicly announced program relates to common stock withheld by us for employees to satisfy their tax withholding obligations arising upon the vesting of performance share units and restricted stock units granted under our Amended and Restated 2014 Stock Incentive Plan.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.